Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant.

Rosko AE, Huang Y, Benson DM, Efebera YA, Hofmeister C, Jaglowski S, Devine S, Bhatt G, Wildes TM, Dyko A, Jones D, Naughton MJ, Byrd JC, Burd CE.

J Geriatr Oncol. 2018 Jul 5. pii: S1879-4068(18)30157-7. doi: 10.1016/j.jgo.2018.05.015. [Epub ahead of print]

PMID:
29983352
2.

Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women's Health Initiative.

Beverly CM, Naughton MJ, Pennell ML, Foraker RE, Young G, Hale L, Feliciano EMC, Pan K, Crane TE, Danhauer SC, Paskett ED.

NPJ Breast Cancer. 2018 Jun 29;4:15. doi: 10.1038/s41523-018-0065-7. eCollection 2018.

3.

Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105.

Naughton MJ, Case LD, Peiffer A, Chan M, Stieber V, Moore D, Falchuk S, Piephoff J, Edenfield W, Giguere J, Loghin M, Shaw EG, Rapp SR.

Neurooncol Pract. 2018 May;5(2):114-121. doi: 10.1093/nop/npx016. Epub 2017 Jul 6.

PMID:
29770225
4.

Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol.

Vitolins MZ, Case LD, Rapp SR, Lively MO, Shaw EG, Naughton MJ, Giguere J, Lesser GJ.

Patient Prefer Adherence. 2018 Apr 24;12:637-646. doi: 10.2147/PPA.S158682. eCollection 2018.

5.

Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: Findings from the WHI LILAC study.

Krok-Schoen JL, Naughton MJ, Bernardo BM, Young GS, Paskett ED.

Psychooncology. 2018 Jul;27(7):1810-1815. doi: 10.1002/pon.4731. Epub 2018 May 16.

PMID:
29644766
6.

Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer.

Alvarez RH, Bechara RI, Naughton MJ, Adachi JA, Reuben JM.

Oncologist. 2018 Jun;23(6):660-669. doi: 10.1634/theoncologist.2017-0343. Epub 2018 Feb 27. Review.

PMID:
29487226
7.

Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.

Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA.

Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13.

PMID:
29442264
8.

Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.

Gabani P, Cyr AE, Zoberi JE, Ochoa LL, Matesa MA, Thomas MA, Garcia J, Margenthaler JA, Naughton MJ, Ma C, Sanati S, Zoberi I.

Brachytherapy. 2018 Jan - Feb;17(1):171-180. doi: 10.1016/j.brachy.2017.09.009. Epub 2017 Oct 28.

PMID:
29089275
9.

Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative.

Felix AS, Lehman A, Foraker RE, Naughton MJ, Bower JK, Kuller L, Sarto GE, Stefanick ML, Van Horn L, Jackson RD, Paskett ED.

Cancer Epidemiol. 2017 Dec;51:62-67. doi: 10.1016/j.canep.2017.10.009. Epub 2017 Oct 16.

PMID:
29049937
10.

Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.

Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, Loprinzi CL, Chaudhari AMW, Lustberg MB.

Breast Cancer Res Treat. 2017 Jul;164(1):69-77. doi: 10.1007/s10549-017-4230-8. Epub 2017 Apr 3.

11.

Association of sleep disturbance and sexual function in postmenopausal women.

Kling JM, Manson JE, Naughton MJ, Temkit M, Sullivan SD, Gower EW, Hale L, Weitlauf JC, Nowakowski S, Crandall CJ.

Menopause. 2017 Jun;24(6):604-612. doi: 10.1097/GME.0000000000000824.

12.

Wireless communication system via nanoscale plasmonic antennas.

Merlo JM, Nesbitt NT, Calm YM, Rose AH, D'Imperio L, Yang C, Naughton JR, Burns MJ, Kempa K, Naughton MJ.

Sci Rep. 2016 Aug 24;6:31710. doi: 10.1038/srep31710.

13.

Shielded Coaxial Optrode Arrays for Neurophysiology.

Naughton JR, Connolly T, Varela JA, Lundberg J, Burns MJ, Chiles TC, Christianson JP, Naughton MJ.

Front Neurosci. 2016 Jun 9;10:252. doi: 10.3389/fnins.2016.00252. eCollection 2016.

14.

Global Quality of Life Among WHI Women Aged 80 Years and Older.

Naughton MJ, Brunner RL, Hogan PE, Danhauer SC, Brenes GA, Bowen DJ, Snively BM, Goveas JS, Saquib N, Zaslavsky O, Shumaker SA.

J Gerontol A Biol Sci Med Sci. 2016 Mar;71 Suppl 1:S72-8. doi: 10.1093/gerona/glv056.

15.

Longitudinal Cognitive Trajectories of Women Veterans from the Women's Health Initiative Memory Study.

Padula CB, Weitlauf JC, Rosen AC, Reiber G, Cochrane BB, Naughton MJ, Li W, Rissling M, Yaffe K, Hunt JR, Stefanick ML, Goldstein MK, Espeland MA.

Gerontologist. 2016 Feb;56(1):115-25. doi: 10.1093/geront/gnv663. Epub 2015 Nov 27.

16.

Aluminum Nanowire Arrays via Directed Assembly.

Nesbitt NT, Merlo JM, Rose AH, Calm YM, Kempa K, Burns MJ, Naughton MJ.

Nano Lett. 2015 Nov 11;15(11):7294-9. doi: 10.1021/acs.nanolett.5b02408. Epub 2015 Oct 30.

PMID:
26505906
17.

Whose quality of life is it anyway? Discrepancies between youth and parent health-related quality of life ratings in type 1 and type 2 diabetes.

Yi-Frazier JP, Hilliard ME, Fino NF, Naughton MJ, Liese AD, Hockett CW, Hood KK, Pihoker C, Seid M, Lang W, Lawrence JM.

Qual Life Res. 2016 May;25(5):1113-21. doi: 10.1007/s11136-015-1158-5. Epub 2015 Oct 14.

18.

Hot electron plasmon-protected solar cell.

Kong J, Rose AH, Yang C, Wu X, Merlo JM, Burns MJ, Naughton MJ, Kempa K.

Opt Express. 2015 Sep 21;23(19):A1087-95. doi: 10.1364/OE.23.0A1087.

PMID:
26406739
19.

Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106.

Greven KM, Case LD, Nycum LR, Zekan PJ, Hurd DD, Balcueva EP, Mills GM, Zon R, Flynn PJ, Biggs D, Shaw EG, Lesser G, Naughton MJ.

J Community Support Oncol. 2015 Mar;13(3):87-94. doi: 10.12788/jcso.0114.

20.

Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors.

Toriola AT, Liu J, Ganz PA, Colditz GA, Yang L, Izadi S, Naughton MJ, Schwartz AL, Wolin KY.

Breast Cancer Res Treat. 2015 Aug;152(3):637-43. doi: 10.1007/s10549-015-3496-y. Epub 2015 Jul 15.

21.

A nanocoaxial-based electrochemical sensor for the detection of cholera toxin.

Archibald MM, Rizal B, Connolly T, Burns MJ, Naughton MJ, Chiles TC.

Biosens Bioelectron. 2015 Dec 15;74:406-10. doi: 10.1016/j.bios.2015.06.069. Epub 2015 Jul 2.

22.

A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.

Lawrence JA, Griffin L, Balcueva EP, Groteluschen DL, Samuel TA, Lesser GJ, Naughton MJ, Case LD, Shaw EG, Rapp SR.

J Cancer Surviv. 2016 Feb;10(1):176-84. doi: 10.1007/s11764-015-0463-x. Epub 2015 Jul 1.

23.

Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.

Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD.

Neuro Oncol. 2015 Oct;17(10):1393-401. doi: 10.1093/neuonc/nov084. Epub 2015 May 12.

24.

Spectroscopic evidence for negative electronic compressibility in a quasi-three-dimensional spin-orbit correlated metal.

He J, Hogan T, Mion TR, Hafiz H, He Y, Denlinger JD, Mo SK, Dhital C, Chen X, Lin Q, Zhang Y, Hashimoto M, Pan H, Lu DH, Arita M, Shimada K, Markiewicz RS, Wang Z, Kempa K, Naughton MJ, Bansil A, Wilson SD, He RH.

Nat Mater. 2015 Jun;14(6):577-82. doi: 10.1038/nmat4273. Epub 2015 Apr 27.

PMID:
25915033
25.

Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer.

Kummar S, Oza AM, Fleming GF, Sullivan DM, Gandara DR, Naughton MJ, Villalona-Calero MA, Morgan RJ Jr, Szabo PM, Youn A, Chen AP, Ji J, Allen DE, Lih CJ, Mehaffey MG, Walsh WD, McGregor PM 3rd, Steinberg SM, Williams PM, Kinders RJ, Conley BA, Simon RM, Doroshow JH.

Clin Cancer Res. 2015 Apr 1;21(7):1574-82. doi: 10.1158/1078-0432.CCR-14-2565. Epub 2015 Jan 14.

26.

Structured metal thin film as an asymmetric color filter: the forward and reverse plasmonic halos.

Ye F, Burns MJ, Naughton MJ.

Sci Rep. 2014 Dec 1;4:7267. doi: 10.1038/srep07267.

27.

Leakage radiation microscope for observation of non-transparent samples.

Merlo JM, Ye F, Burns MJ, Naughton MJ.

Opt Express. 2014 Sep 22;22(19):22895-904. doi: 10.1364/OE.22.022895. Erratum in: Opt Express. 2014 Oct 20;22(21):25924.

PMID:
25321760
28.

Nanocoaxes for optical and electronic devices.

Rizal B, Merlo JM, Burns MJ, Chiles TC, Naughton MJ.

Analyst. 2015 Jan 7;140(1):39-58. doi: 10.1039/c4an01447b. Review.

29.
30.

Near-field observation of light propagation in nanocoax waveguides.

Merlo JM, Ye F, Rizal B, Burns MJ, Naughton MJ.

Opt Express. 2014 Jun 16;22(12):14148-54. doi: 10.1364/OE.22.014148.

PMID:
24977513
31.

Nanoscope based on nanowaveguides.

Rose AH, Wirth BM, Hatem RE, Ahmed AP, Burns MJ, Naughton MJ, Kempa K.

Opt Express. 2014 Mar 10;22(5):5228-33. doi: 10.1364/OE.22.005228.

PMID:
24663862
32.

Longitudinal associations between sex, diabetes self-care, and health-related quality of life among youth with type 1 or type 2 diabetes mellitus.

Naughton MJ, Yi-Frazier JP, Morgan TM, Seid M, Lawrence JM, Klingensmith GJ, Waitzfelder B, Standiford DA, Loots B; SEARCH for Diabetes in Youth Study Group.

J Pediatr. 2014 Jun;164(6):1376-83.e1. doi: 10.1016/j.jpeds.2014.01.027. Epub 2014 Feb 26.

33.

A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.

Roop RP, Naughton MJ, Van Poznak C, Schneider JG, Lammers PE, Pluard TJ, Johnson F, Eby CS, Weilbaecher KN.

Clin Breast Cancer. 2013 Dec;13(6):409-15. doi: 10.1016/j.clbc.2013.08.006.

34.

Nanocoax-based electrochemical sensor.

Rizal B, Archibald MM, Connolly T, Shepard S, Burns MJ, Chiles TC, Naughton MJ.

Anal Chem. 2013 Nov 5;85(21):10040-4. doi: 10.1021/ac402441x. Epub 2013 Oct 21.

PMID:
24090275
35.

Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment.

Avis NE, Levine B, Naughton MJ, Case LD, Naftalis E, Van Zee KJ.

Breast Cancer Res Treat. 2013 May;139(1):199-206. doi: 10.1007/s10549-013-2513-2. Epub 2013 Apr 16.

36.

Plasmonic halos--optical surface plasmon drumhead modes.

Ye F, Burns MJ, Naughton MJ.

Nano Lett. 2013 Feb 13;13(2):519-23. doi: 10.1021/nl303955x. Epub 2013 Jan 9.

PMID:
23249310
37.

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.

Ma CX, Ellis MJ, Petroni GR, Guo Z, Cai SR, Ryan CE, Craig Lockhart A, Naughton MJ, Pluard TJ, Brenin CM, Picus J, Creekmore AN, Mwandoro T, Yarde ER, Reed J, Ebbert M, Bernard PS, Watson M, Doyle LA, Dancey J, Piwnica-Worms H, Fracasso PM.

Breast Cancer Res Treat. 2013 Jan;137(2):483-92. doi: 10.1007/s10549-012-2378-9. Epub 2012 Dec 15.

38.

Female sex work within the rural immigrant Latino community in the southeast United States: an exploratory qualitative community-based participatory research study.

Rhodes SD, Tanner A, Duck S, Aronson RE, Alonzo J, Garcia M, Wilkin AM, Cashman R, Vissman AT, Miller C, Kroeger K, Naughton MJ.

Prog Community Health Partnersh. 2012 Winter;6(4):417-27. doi: 10.1353/cpr.2012.0054.

39.

Explaining age-related differences in depression following breast cancer diagnosis and treatment.

Avis NE, Levine B, Naughton MJ, Case DL, Naftalis E, Van Zee KJ.

Breast Cancer Res Treat. 2012 Nov;136(2):581-91. doi: 10.1007/s10549-012-2277-0. Epub 2012 Oct 9.

40.

A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.

Lesser GJ, Case D, Stark N, Williford S, Giguere J, Garino LA, Naughton MJ, Vitolins MZ, Lively MO, Shaw EG; Wake Forest University Community Clinical Oncology Program Research Base.

J Support Oncol. 2013 Mar;11(1):31-42.

41.

Ultrasensitive chemical detection using a nanocoax sensor.

Zhao H, Rizal B, McMahon G, Wang H, Dhakal P, Kirkpatrick T, Ren Z, Chiles TC, Naughton MJ, Cai D.

ACS Nano. 2012 Apr 24;6(4):3171-8. doi: 10.1021/nn205036e. Epub 2012 Mar 12.

PMID:
22393880
42.

Phase II trial of temsirolimus in patients with metastatic breast cancer.

Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ.

Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13.

43.

A multicenter prospective trial evaluating fetal bovine dermal graft (Xenform® Matrix) for pelvic reconstructive surgery.

Goldstein HB, Maccarone J, Naughton MJ, Aguirre OA, Patel RC.

BMC Urol. 2010 Dec 13;10:21. doi: 10.1186/1471-2490-10-21.

44.

Observation and simulation of all angular magnetoresistance oscillation effects in the quasi-one-dimensional organic conductor (DMET)(2)I(3).

Dhakal P, Yoshino H, Oh JI, Kikuchi K, Naughton MJ.

Phys Rev Lett. 2010 Aug 6;105(6):067201. Epub 2010 Aug 2.

PMID:
20868001
45.

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.

Fracasso PM, Williams KJ, Chen RC, Picus J, Ma CX, Ellis MJ, Tan BR, Pluard TJ, Adkins DR, Naughton MJ, Rader JS, Arquette MA, Fleshman JW, Creekmore AN, Goodner SA, Wright LP, Guo Z, Ryan CE, Tao Y, Soares EM, Cai SR, Lin L, Dancey J, Rudek MA, McLeod HL, Piwnica-Worms H.

Cancer Chemother Pharmacol. 2011 Jun;67(6):1225-37. doi: 10.1007/s00280-010-1410-1. Epub 2010 Aug 8.

46.

A molecular-imprint nanosensor for ultrasensitive detection of proteins.

Cai D, Ren L, Zhao H, Xu C, Zhang L, Yu Y, Wang H, Lan Y, Roberts MF, Chuang JH, Naughton MJ, Ren Z, Chiles TC.

Nat Nanotechnol. 2010 Aug;5(8):597-601. doi: 10.1038/nnano.2010.114. Epub 2010 Jun 27.

47.

Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.

Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, Naftalis E, Naughton MJ.

Cancer. 2010 Jul 1;116(13):3102-11. doi: 10.1002/cncr.25106.

48.

A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy.

Lin Y, Lin S, Watson M, Trinkaus KM, Kuo S, Naughton MJ, Weilbaecher K, Fleming TP, Aft RL.

Breast Cancer Res Treat. 2010 Oct;123(3):691-9. doi: 10.1007/s10549-009-0664-y. Epub 2009 Dec 6.

49.

A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.

Wong KK, Fracasso PM, Bukowski RM, Lynch TJ, Munster PN, Shapiro GI, Jänne PA, Eder JP, Naughton MJ, Ellis MJ, Jones SF, Mekhail T, Zacharchuk C, Vermette J, Abbas R, Quinn S, Powell C, Burris HA.

Clin Cancer Res. 2009 Apr 1;15(7):2552-8. doi: 10.1158/1078-0432.CCR-08-1978. Epub 2009 Mar 24.

50.

Breast cancer survivors' health-related quality of life : racial differences and comparisons with noncancer controls.

Paskett ED, Alfano CM, Davidson MA, Andersen BL, Naughton MJ, Sherman A, McDonald PG, Hays J.

Cancer. 2008 Dec 1;113(11):3222-30. doi: 10.1002/cncr.23891.

Supplemental Content

Loading ...
Support Center